An initiative of IBA Proton Therapy
Campus your proton
therapy community
  • Resource center
  • Training
  • Events
  • About
  • Log in
  • Resource center
  • Training
  • Events
  • About
  • Log in
An initiative of IBA Proton Therapy

Your results for

Filter by

Filter by
Results

Filter by

Content type
  • Event - Do not use (0)
  • Podcast (0)
  • Publications (16)
  • Training (0)
  • User case (0)
  • User meeting (0)
  • Webinar (0)
  • White paper (1)
Key content topics
Key audience
  • Newcomers (0)
Top cancer treatments
  • Brain and CNS (1)
  • (-) Breast (5)
  • (-) Gastro-intestinal (12)
  • Genito-urinary (2)
  • Gynecological (0)
  • Head and neck (6)
  • Hodgkin and Non-Hodgkin lymphoma (1)
  • Ocular (1)
  • Pediatric (4)
  • Reirradiation (2)
  • Sarcomas (3)
  • Thoracic (5)
  • Reset filters
  • (-) Dosimetry
  • (-) Breast
  • (-) Gastro-intestinal

Proton beam therapy for liver cancers.

03/02/2020
/ Publications
/
Dosimetry
Toxicity

A review article examined the latest utilization of PBT for hepatocellular carcinoma and cholangiocarcinoma, as well as liver metastasis. The dosimetric...

Early and late side effects, dosimetric parameters and QoL after PBT and IMRT for prostate cancer

03/03/2019
/ Publications
/
Dosimetry

A study by the researchers of Dresden and Heidelberg. Eighty-eight patients with localized prostate cancer treated with PBT (31) or IMRT (57) were matched using...

Proton Therapy for Prostate Cancer

11/09/2018
/ Publications
/
Dosimetry
Clinical Trial

A review examined the dosimetric rationale and theoretical benefit of proton radiation for prostate cancer and the current state of the clinical evidence for...

Proton Therapy for Primary Breast Cancer.

08/06/2018
/ Publications
/
Dosimetry
Clinical Trial

A review by Hug EB on PT for breast cancer. The author stated that in a small but significant percentage of patients requiring adjuvant radiotherapy for left...

Finding Value for Protons: The Case of Prostate Cancer?

05/04/2018
/ Publications
/
Dosimetry
Quality of life

A review by UPenn examined the dosimetric data and clinical outcome reports. Clinical studies largely suggest no difference in urinary side effects or erectile...

Potential Morbidity Reduction with Proton Radiation Therapy for Breast Cancer.

04/04/2018
/ Publications
/
Dosimetry
Chemotherapy

A systematic review by MSKCC about the increasing emphasis on the mitigation of iatrogenic morbidity, with particular attention to heart and lung exposure in...

Executive Summary of Clinical and Technical Guidelines for Esophageal Cancer Proton Beam Therapy From the Particle Therapy Co-Operative Group Thoracic and Gastrointestinal Subcommittees.

10/10/2021
/ Publications
/
Dosimetry
Reirradiation
Motion Management

 In this guideline document, the dosimetric data and clinical evidence of PBT for esophageal cancer (EC) was summarized and evaluated. The clinical outcome data...

Treating gastrointestinal malignancy with proton therapy

01/10/2016
/ White Paper
/
Toxicity
Dosimetry
Chemotherapy

The improved dosimetry with proton therapy enables greater sparing of normal tissues and...

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy.

16/05/2021
/ Publications
/
Dosimetry
Reirradiation
Toxicity

A review article compared the clinical evidence including the parameters of the dose distribution in organs at risk, such as the heart, blood vessels, and lungs...

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.

16/03/2023
/ Publications
/
Dosimetry
Hypofractionation
Toxicity

Fifty patients were treated with PT using two different regimens following lumpectomy. 14 patients received IMPT to a total dose of 50 Gy in 25 fractions...

Pagination

    • Current page 1
    • Page 2
  • Next page ›
Campus
Subscribe to our newsletter
Follow us on
  • Facebook
  • Linkedin
  • Twitter
  • Youtube
Contact us
  • About Campus
  • Resources
  • Training
  • Connect
  • IBA Worldwide
  • Back to IBA Proton Therapy
Life Science
  • Legal
  • Terms of Use
  • Privacy policy
  • Cookies policy
  • Manage cookies
  • Code of conduct

Cookies policy

If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.

Manage your cookie preferences

Respect for your privacy is still a priority for us at IBA.

Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.

Accept all cookies
Adapt my preferences
Cookies policies